Study of the effect of curcumin on rheumatism

INTERVENTION: In the control group, for 3 months, patients received placebo treatment at a dose of 80 mg (as capsule 80 mg placebo) per day In the intervention group for 3 months, patients treated with curcumin (in the form of nanomissile) are given as 80 mg (80 mg capsules) per day. Intervention 1: In the intervention group for 3 months, patients treated with curcumin (in the form of nanomissile) are given as 80 mg (80 mg capsules) per day. Intervention 2: In the control group, for 3 months, patients received placebo treatment at a dose of 80 mg (as capsule 80 mg placebo) per day. Placebo Treatment ‐ Drugs CONDITION: Arthritis Rheumatoid. ; Rheumatoid arthritis, unspecified Rheumatoid arthritis, unspecified PRIMARY OUTCOME: Disease activity. Timepoint: Before taking curcumin and 3 months after taking curcumin. Method of measurement: Questionnaire DAS 28 ( Disease Activity Square 28). INCLUSION CRITERIA: Diagnosed with RA according to eular criteria Personal satisfaction